Admedus OTC Stock Buy Hold or Sell Recommendation

AMEUF
 Stock
  

USD 14.89  2.13  12.51%   

Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Admedus is 'Strong Sell'. Macroaxis provides Admedus buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Admedus positions. The advice algorithm takes into account all of Admedus' available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Admedus' buy-and-hold perspective. Please continue to Admedus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Admedus and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Admedus.

Execute Admedus Buy or Sell Advice

The Admedus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Admedus. Macroaxis does not own or have any residual interests in Admedus or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Admedus' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell AdmedusBuy Admedus
Strong Sell

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Not Available
Details

Reporting Quality (M-Score)

Details
For the selected time horizon Admedus has a Mean Deviation of 1.6, Standard Deviation of 3.54 and Variance of 12.56
Our trade advice tool can cross-verify current analyst consensus on Admedus and to analyze the company potential to grow in the current economic cycle. To make sure Admedus is not overpriced, please confirm all Admedus fundamentals, including its total debt, market capitalization, and the relationship between the ebitda and cash flow from operations . Given that Admedus has a price to earning of (3.20) X, we suggest you to validate Admedus market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Admedus Trading Alerts and Improvement Suggestions

Admedus generated a negative expected return over the last 90 days
Admedus has high historical volatility and very poor performance
The company reported the revenue of 7.1 M. Net Loss for the year was (34.69 M) with profit before overhead, payroll, taxes, and interest of 6.15 M.
Admedus has accumulated about 33.1 M in cash with (32.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.39.
Roughly 13.0% of the company shares are held by company insiders

Admedus Returns Distribution Density

The distribution of Admedus' historical returns is an attempt to chart the uncertainty of Admedus' future price movements. The chart of the probability distribution of Admedus stock daily returns describes the distribution of returns around its average expected value. We use Admedus price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Admedus returns is essential to provide solid investment advice for Admedus.
Mean Return-0.17Value At Risk-4.97
Potential Upside3.38Standard Deviation3.54
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Admedus historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Admedus Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Admedus or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Admedus' price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Admedus otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.2
β
Beta against DOW-0.12
σ
Overall volatility
3.90
Ir
Information ratio -0.02

Admedus Volatility Alert

Admedus exhibits very low volatility with skewness of 2.54 and kurtosis of 16.0. However, we advise investors to further study Admedus technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Admedus' otc stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Admedus' otc stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Admedus Fundamentals Vs Peers

Comparing Admedus' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Admedus' direct or indirect competition across all of the common fundamentals between Admedus and the related equities. This way, we can detect undervalued stocks with similar characteristics as Admedus or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Admedus' fundamental indicators could also be used in its relative valuation, which is a method of valuing Admedus by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Admedus to competition
FundamentalsAdmedusPeer Average
Return On Equity(255.17) %(0.31) %
Return On Asset(84.33) %(0.14) %
Operating Margin(504.89) %(5.51) %
Current Valuation206.15 M16.62 B
Shares Outstanding13.9 M571.82 M
Shares Owned by Insiders13.27 %10.09 %
Shares Owned by Institutions28.35 %39.21 %
Price to Earning(3.20) X28.72 X
Price to Book6.60 X9.51 X
Price to Sales27.31 X11.42 X
Revenue7.1 M9.43 B
Gross Profit6.15 M27.38 B
EBITDA(35.01 M)3.9 B
Net Income(34.69 M)570.98 M
Cash and Equivalents33.1 M2.7 B
Cash per Share2.39 X5.01 X
Total Debt4.07 M5.32 B
Debt to Equity0.13 %48.70 %
Current Ratio4.31 X2.16 X
Book Value Per Share2.26 X1.93 K
Cash Flow from Operations(32.52 M)971.22 M
Earnings Per Share(2.15) X3.12 X
Number of Employees1218.84 K
Beta0.58-0.15
Market Capitalization193.91 M19.03 B
Total Asset27 M29.47 B
Retained Earnings(69 M)9.33 B
Working Capital13 M1.48 B
Current Asset17 M9.34 B
Current Liabilities4 M7.9 B
Z Score22.18.72

Admedus Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Admedus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Admedus Buy or Sell Advice

When is the right time to buy or sell Admedus? Buying financial instruments such as Admedus OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Admedus in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Health Management Thematic Idea Now

Health Management
Health Management Theme
Major hospitals and healthcare providers. The Health Management theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Management Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Admedus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for analysis

When running Admedus price analysis, check to measure Admedus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Admedus is operating at the current time. Most of Admedus' value examination focuses on studying past and present price action to predict the probability of Admedus' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Admedus' price. Additionally, you may evaluate how the addition of Admedus to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Is Admedus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Admedus. If investors know Admedus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Admedus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Admedus is measured differently than its book value, which is the value of Admedus that is recorded on the company's balance sheet. Investors also form their own opinion of Admedus' value that differs from its market value or its book value, called intrinsic value, which is Admedus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Admedus' market value can be influenced by many factors that don't directly affect Admedus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Admedus' value and its price as these two are different measures arrived at by different means. Investors typically determine Admedus value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Admedus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.